Trevena Stock News

Trevena, Inc. (TRVN) with the stream of -1.79% also noticed, India Pulmatrix, Inc. (PULM) encountered a rapid change of -2.84% in the last hour of Monday’s trading session. Trevena, Inc. … The post A Few Positives and Negatives For: Trevena, Inc. (NASDAQ:TRVN), Pulmatrix, Inc. (NASDAQ:PULM) appeared first on Stocks Equity .

In the last trading session, 1.89 million shares of the Trevena Inc. (NASDAQ:TRVN) were traded, and its beta was 2.16. Most recently the companys share price was $0.74, and it changed around $0.0 or 0.11% from the last close, which brings the market valuation of the company to $121.11M. TRVN currently trades at a discount Trevena Inc. (NASDAQ: TRVN): A Competitive Analysis And Growth Prospects Read More »

Trevena, Inc. (NASDAQ:TRVN) Stock analysts at Oppenheimer increased their FY2021 earnings per share estimates for shares of Trevena in a research report issued to clients and investors on Monday, November 15th. Oppenheimer analyst J. Jones now forecasts that the biopharmaceutical company will post earnings of ($0.31) per share for the year, up from their []

Trevena Inc. (NASDAQ:TRVN) price on Thursday, November 18, fall -7.11% below its previous days close as a downside momentum from buyers pushed the stocks value to $0.74. A look at the stocks price movement, the close in the last trading session was $0.79, moving within a range at $0.73 and $0.7979. The beta value (5-Year Analysts Predicting A Spike In Trevena Inc. (NASDAQ: TRVN)? Read More »

Trevena, Inc. (TRVN) with the stream of -3.78% also noticed, India United Microelectronics Corporation (UMC) encountered a rapid change of -0.62% in the last hour of Tuesdays trading session. Trevena, The post Flaming Stock: Trevena, Inc. (NASDAQ:TRVN), United Microelectronics Corporation (NYSE:UMC) appeared first on Stocks Equity .

Trevena (NASDAQ:TRVN) released its quarterly earnings data on Monday. The biopharmaceutical company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.01, MarketWatch Earnings reports. Trevena had a negative net margin of 1,194.62% and a negative return on equity of 40.89%. During the same period last year, the company []

Trevena (TRVN) delivered earnings and revenue surprises of 11.11% and -84.42%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Trevena (TRVN) delivered earnings and revenue surprises of 11.11% and -84.42%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Trevena, Inc. (TRVN) CEO Carrie Bourdow on Q3 2021 Results - Earnings Call Transcript

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences. Among the

Company to host conference call on Monday, November 15th, 2021 at 8:00 a.m. ET Company to host conference call on Monday, November 15th, 2021 at 8:00 a.m. ET

Will upcoming events mean big things for these penny stocks? The post 5 Penny Stocks To Watch This Week With Potential Biotech Catalysts appeared first on Penny Stocks to Buy, Picks, News and Informat

Trevena Inc (NASDAQ: TRVN) has announced data from 30 patients enrolled in the proof-of-concept study of TRV027 in hospitalized COVID-19 patients.  The results showed that TRV027 was well-tolerate